Recently, a study found that OCN level was lower in CSF of 6-hydroxydopamine-induced PD rats than that in sham rats, and administration of OCN could ameliorate behavioral dysfunctions associated with PD (Guo et al., 2018). This evidence concerns the gene BGLAP and Parkinson disease.